30 Nov 20

Accurate diagnosis is essential for effective treatment of dentine hypersensitivity (DH), and patients should all be treated as individuals, working with the clinician to manage their condition.

This was the consensus of an international panel of experts, known for their work in the field of DH, and shared with attendees at BioMin’s recent webinar on the subject.

Chaired by dental hygienist and presenter Victoria Wilson, over 700 delegates from more than 50 countries registered for the webinar, which counted for one hour of GDC-compliant CPD. In an innovative move, throughout the webinar attendees took part in online polls, asking about their own experience of managing DH, and the results were displayed onscreen in real-time.

Dr. David Gillam, Clinical Reader at the Barts London School of Medicine and Dentistry (QMUL) and Clinical Consultant to BioMin Technologies Ltd, stressed the importance of correct diagnosis, and the opportunity to rediagnose if the first diagnosis was incorrect. Warning his audience not to underestimate the effect of DH on quality of life, he said: ‘It’s important for the clinician to have a management strategy.’ From the patient’s side, ‘they need to change behaviour, take ownership of their own mouth, for example in terms of diet and brushing technique.’

Dentine Hypersensitivity Suggested Treatment Plan

Donna Paton, former President of the Irish Dental Hygienists’ Association and a highly experienced dental hygienist in Ireland, said that she always took time to explain the theory behind DH to patients and work with them to address the problem and find solutions. A user of BioMin herself, she believes it is an ideal product to recommend for DH, whatever the cause, and for patients who need ‘a bit of TLC for their enamel’.

This opinion was shared by Yorkshire hygienist Gill Wallis-Cliffe, who has been recommending BioMin F since 2016. She described the science behind it as ‘compelling and wonderful,’ and said that she too involved the patient in discussing their DH and possible treatments. Many of her patients come from lower socio-economic groups and have a poor diet, so ‘to be able to recommend a product that is going to work really well and cover more angles has been great,’ she said. ‘With BioMin F – which is fantastic – we have a toothpaste which we can stock and support as a professional product.’

Bringing an international perspective, Gitana Rederiene, President of the Lithuanian Dental Hygienists’ Association, gave her view both as a clinician and a distributor of dental products. ‘As a hygienist, I always focus on the problems of the patient,’ she said. ‘We look at their problems and try together to find solutions. As a specialist, I am always keen to give something new, innovative and scientifically proven – and as a distributor, I focus on the same things.’ She recommends BioMin F not only for patients suffering from DH but also for remineralising the enamel of periodontal patients with gum recession.

Finally, Dr. Stefano Daniele, a clinician, and university tutor from Milan, Italy, gave his view. His own research into BioMin F (link here) has shown that BioMin F reduced or even solved the symptoms of DH in his study group of patients, with 73% of them saying it was more effective than other ‘sensitivity’ toothpastes they had tried. Dr. Daniele is starting a new study, involving a questionnaire about DH, and is looking for clinicians to take part in it. If you are interested in joining the study, email info@biomin.co.uk, subject ‘clinical evaluation’.

A video of the full webinar is available on BioMin’s e-Academy, worth 1 hour of free GDC-compliant CPD. You can register on biomin.co.uk/e-academy